Search

Your search keyword '"Johansen, Mary"' showing total 251 results

Search Constraints

Start Over You searched for: Author "Johansen, Mary" Remove constraint Author: "Johansen, Mary"
251 results on '"Johansen, Mary"'

Search Results

2. A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia.

7. Factors contributing to nurses' intent to leave during COVID‐19.

8. A theoretical framework for Acute Care Nurse Stress Appraisal: Application of the transactional model of stress and coping.

15. A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors

19. First-Person Assignments: Considering How History Affects and Is Affected by the Individual

22. A phase 1, first-in-human, dose-escalation and biomarker trial of liposomal gemcitabine (FF-10832) in patients with advanced solid tumors.

23. A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors.

33. Tillitsbasert styring og ledelse - Hvordan har styringspraksis endret seg i Oslo kommune etter innføringen av tillitsbasert styring og ledelse?

35. Phase 1 first-in-human study of irreversible FLT3 inhibitor FF-10101-01 in relapsed or refractory acute myeloid leukemia.

37. Autophagic Cell Death of Human Pancreatic Tumor Cells Mediated by Oleandrin, a Lipid-Soluble Cardiac Glycoside

38. Phase I expansion study of P-cadherin-targeted 90Y-FF-21101 antibody in advanced chemorefractory colorectal and pancreatic-biliary cancers.

42. Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

47. Phase 1/2 trial of FF-10502-01, a pyrimidine antimetabolite, in patients with advanced cholangiocarcinoma and solid tumors.

48. A phase I dose-escalation and immune biomarker study of intravenous FF-10832, liposomal gemcitabine, in patients with advanced solid tumors.

Catalog

Books, media, physical & digital resources